Li et al. [55] indicated that ARF6 can regulate the functions of membrane traffic, and overexpression of ARF6 was correlated with poor prognosis in multiple invasive cancers, such as triple-negative breast cancer and invasive clear cell renal cell carcinoma. Here, ARF6 is linked to triple-negative breast carcinoma.